Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S54, 2018. DOI: 10.25251/skin.2.supp.54. Disponível em: https://skin.dermsquared.com/skin/article/view/289. Acesso em: 6 oct. 2025.